⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

SAMMAANCAP - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 2.3

Last Updated Time : 13 Sept 26, 01:37 pm

Key Parameters

⭐ Fundamental Rating: 2.3

ROE-5.14 %
ROCE3.24 %
Industry PE13.2
Debt to equity2.41
EPS-64.3 ₹
Book Value172 ₹
Stock CodeSAMMAANCAP
Market Cap17,112 Cr.
Show all parameters (18 more)
Current Price147 ₹
High / Low193 ₹
Dividend Yield0.00 %
Face Value2.00 ₹
DMA 50156 ₹
DMA 200155 ₹
Chg in FII Hold-26.6 %
Chg in DII Hold-4.14 %
PAT Qtr226 Cr.
PAT Prev Qtr-1,956 Cr.
RSI39.5
MACD-2.17
Volume42,82,582
Avg Vol 1Wk45,22,481
Low price129 ₹
High price193 ₹
52w Index28.6 %
Qtr Profit Var-24.2 %

🏭 Industry

The financial services sector, particularly investment management, typically operates with relatively thin margins and significant regulatory scrutiny, demanding careful capital allocation and robust risk management practices. Competition is fierce, leading to pressure on fee structures and potentially impacting profitability depending on asset under management (AUM) growth.

✅ Positive

Sammaan Capital demonstrated a significant rebound in profitability with PAT Qtr rising to 226 Cr compared to the previous quarter’s loss of 1956 Cr. The company maintains a conservative capital structure indicated by a debt-to-equity ratio of 2.41 and very low dividend yield, suggesting disciplined financial management focused on reinvestment rather than shareholder payouts.

⚠️ Limitation

The negative ROE (-5.14%) raises concerns about the sustainability of returns relative to its asset base, especially given the high debt levels. Furthermore, a significant decrease in FII holding alongside a modest DII decline suggests waning institutional investor confidence which could reflect underlying business quality or future growth prospects.

📉 Company Negative News

The EGM being adjourned for quorum and the resumption of discussion regarding Crasta’s director appointment introduces uncertainty around corporate governance and potentially raises questions about shareholder influence. Additionally, the Open Offer has yielded zero shares tendered through April 20, 2026, indicating limited demand for shares at the offered price which may signal low investor confidence.

🧾 Long-Term Outlook

Given the recent turnaround in profitability and a debt-to-equity ratio of 2.41, an entry zone could be established around 135 ₹, offering a margin of safety considering the substantial prior losses and negative ROE. A long-term holding strategy would require close monitoring of AUM growth, fee compression trends, and the resolution of the governance concerns surrounding the director appointment. Ultimately, this investment remains cautiously optimistic pending further evidence of sustained improvement in returns and management’s ability to navigate the competitive landscape.

Choose Technical Analysis or Fundamental Analysis above to load it.

How SAMMAANCAP Rates Across All Strategies

★ 2.8
Entry Price: 142 ₹ – Taking a long position at the current price allo…
★ 2.3
Buy Price: 145 ₹ (targeting immediate momentum).
★ 2.3
An ideal entry price zone would be between 130 ₹ and 140 ₹, capitaliz…
Fundamental
★ 2.3
You're viewing this analysis below.

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental